Kimberly Goodspeed
Ultragenyx Pharmaceutical (United States)
ORCID: 0000-0002-8823-2839Also affiliated with The University of Texas Southwestern Medical Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Top data-sharing exemplar
The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.
Eduardo Pérez‐Palma, Tobias Brünger, Ludovica Montanucci, Cornelius Gati, Chiara Klöckner +41 more
Papers
Driven by 5 papers — median percentile 67. Top paper: “Current Clinical Applications of In Vivo Gene Therapy with AAVs”.
Samiah Al-Zaidy, Louise R. Rodino‐Klapac, Kimberly Goodspeed, Steven J. Gray, Christine N. Kay +7 more
Eduardo Pérez‐Palma, Tobias Brünger, Ludovica Montanucci, Cornelius Gati, Chiara Klöckner +41 more
Darlene DeVries, Ashlesha Gogate, Kiran Kaur, Ashwani Kumar, Chao Xing +4 more
Rachel M. Bailey, Suyash Prasad, Chanchal Sadhu, Jessica Cardenas, Mary Holmay +3 more
Yuliya Voskobiynyk, Kimberly Goodspeed, Jeanne T. Paz, Britta E. Lindquist